Metropolis Healthcare acquires Core Diagnostics to lead in cancer testing
Metropolis Healthcare Limited, a leading name in India’s pathology sector, has announced the acquisition of Core Diagnostics, marking a transformative step towards becoming the nation’s ... Read More
Metropolis Healthcare’s Q2 profits skyrocket 31% – is this the start of unstoppable growth?
Metropolis Healthcare Limited, one of India’s prominent diagnostic chains, has reported a significant year-on-year profit growth of 31.0% in Q2 FY2024-25. This sharp increase is ... Read More
How Metropolis Healthcare achieved a stunning revenue growth in Q1 FY25
Metropolis Healthcare Limited (NSE: METROPOLIS | BSE: 542650), a leading diagnostic chain in India, has announced a significant financial milestone with a 13.1% year-on-year increase ... Read More
Metropolis Healthcare wraps up acquisition of Hitech Diagnostic Centre
Metropolis Healthcare, an Indian diagnostic service provider, has wrapped up the previously announced INR 636 crores acquisition of Dr. Ganesan’s Hitech Diagnostic Centre along with ... Read More
Metropolis Healthcare indicates scrapping of Hitech Diagnostic Centre deal
Metropolis Healthcare indicated that its previously announced acquisition of Dr. Ganesan’s Hitech Diagnostic Centre and its subsidiary Centralab Healthcare Services is likely to be terminated. ... Read More